English   español  

Browsing by Author rp08212

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 20 of 23  next >
RightsPreviewIssue DateTitleAuthor(s)Type
closedAccessaccesoRestringido.pdf.jpg2008Aplidin, a marine organism-derived compound with potent antimyeloma activity in vitro and in vivoMitsiades, C. S.; Ocio, Enrique M. CSIC ORCID ; Pandiella, Atanasio CSIC ORCID CVN ; Maiso, Patricia; Gajate, Consuelo CSIC ORCID ; Garayoa, Mercedes CSIC ORCID ; Vilanova, David; Montero, Juan Carlos CSIC ORCID; Mollinedo, Faustino CSIC ORCID ; San Miguel, Jesús F. CSIC ORCIDartículo
openAccessCD20 positive.pdf.jpg2012CD20 positive cells are undetectable in the majority of multiple myeloma cell lines and are not associated with a cancer stem cell phenotypePaíno, Teresa CSIC ORCID; Ocio, Enrique M. CSIC ORCID ; Paiva, Bruno; San-Segundo, Laura; Garayoa, Mercedes CSIC ORCID ; Gutiérrez, Norma Carmen; Sarasquete, María Eugenia; Pandiella, Atanasio CSIC ORCID CVN ; Orfao, Alberto CSIC ORCID ; San Miguel, Jesús F. CSIC ORCIDartículo
openAccessDasatinib as.pdf.jpg2012Dasatinib as a bone-modifying agent: Anabolic and anti-resorptive effectsGarcía-Gómez, Antonio; Ocio, Enrique M. CSIC ORCID ; Crusoe, Edvan; Santamaría, Carlos; Hernández-Campo, Pilar M.; Blanco, Juan F.; Sánchez-Guijo, Fermín M.; Hernández, M. Teresa CSIC; Pandiella, Atanasio CSIC ORCID CVN ; San Miguel, Jesús F. CSIC ORCID; Garayoa, Mercedes CSIC ORCID ; Briñón, Jesús G.artículo
closedAccessaccesoRestringido.pdf.jpg2019Dihydropyrimidine-2-thiones as Eg5 inhibitors and L-type calcium channel blockers: Potential antitumour dual agentsGonzález-Hernández, Elena; Aparicio, Rubén; Garayoa, Mercedes CSIC ORCID ; Montero, María J.; Sevilla, Mª Ángeles; Pérez-Melero, Concepciónartículo
closedAccessaccesoRestringido.pdf.jpg2020Filanesib for the treatment of multiple myelomaAlgarín, Esperanza M.; Hernández-García, Susana; Garayoa, Mercedes CSIC ORCID ; Ocio, Enrique M. CSIC ORCID artículo
openAccess10.3324-haematol.2009.015495.pdf.jpg1-May-2010In vitro and in vivo rationale for the triple combination of panobinostat (LBH589) and dexamethasone with either bortezomib or lenalidomide in multiple myelomaOcio, Enrique M. CSIC ORCID ; Vilanova, David; Maiso, Patricia; Crusoe, Edvan; Fernández-Lázaro, Diego; Garayoa, Mercedes CSIC ORCID ; San-Segundo, Laura; Hernández, M. Teresa CSIC; San Miguel, Jesús F. CSIC ORCIDartículo
closedAccessaccesoRestringido.pdf.jpg2015In vivo murine model of acquired resistance in myeloma reveals differential mechanisms for lenalidomide and pomalidomide in combination with dexamethasoneOcio, Enrique M. CSIC ORCID ; Fernández-Lázaro, Diego; San-Segundo, Laura; López-Corral, L.; Corchete, Luis A.; Gutiérrez, Norma Carmen; Garayoa, Mercedes CSIC ORCID ; Paíno, Teresa CSIC ORCID; García-Gómez, Antonio; Delgado, Manuel; Montero, Juan Carlos CSIC ORCID; Díaz-Rodríguez, Elena CSIC ORCID CVN; Mateos, Maria Victoria; Pandiella, Atanasio CSIC ORCID CVN ; San Miguel, Jesús F. CSIC ORCIDartículo
closedAccessaccesoRestringido.pdf.jpg2009Mesenchymal stem cells from multiple myeloma patients display distinct genomic profile as compared with those from normal donorsGenomic profile of multiple myeloma MSCsGarayoa, Mercedes CSIC ORCID ; García, Juan L. CSIC ORCID CVN ; Santamaría, Carlos; García-Gómez, Antonio; Blanco, Juan F.; Pandiella, Atanasio CSIC ORCID CVN ; Hernández, Jesús M. CSIC ORCID ; Sánchez-Guijo, Fermín M.; Cañizo, María Consuelo del; Gutiérrez, Norma Carmen; San Miguel, Jesús F. CSIC ORCIDartículo
openAccessMultipleMyelomaCellLines.PDF.jpg2014Phenotypic, genomic and functional characterization reveals no differences between CD138++ and CD138low subpopulations in multiple myeloma cell linesPaíno, Teresa CSIC ORCID; Sarasquete, María Eugenia; Paiva, Bruno; Krzemiński, Patryk; San-Segundo, Laura; Corchete, Luis A.; Redondo, Alba; Garayoa, Mercedes CSIC ORCID ; García-Sanz, Ramón; Gutiérrez, Norma Carmen; Ocio, Enrique M. CSIC ORCID ; San Miguel, Jesús F. CSIC ORCIDartículo
closedAccessaccesoRestringido.pdf.jpg2014Preclinical activity of the oral proteasome inhibitor mln9708 in myeloma bone diseaseGarcía-Gómez, Antonio; Ocio, Enrique M. CSIC ORCID ; Blanco, Juan F.; Hernández-Iglesias, Teresa; Fraile, Susana CSIC; San Miguel, Jesús F. CSIC ORCID; Garayoa, Mercedes CSIC ORCID artículo
openAccesspreclirepai.pdf.jpg2017Preclinical anti-myeloma activity of EDO-S101, a new bendamustine-derived molecule with added HDACi activity, through potent DNA damage induction and impairment of DNA repairLópez-Iglesias, Ana-Alicia; Herrero, Ana B.; Chesi, Marta; San-Segundo, Laura; González-Méndez, Lorena; Hernández-García, Susana; Misiewicz-Krzeminska, Irena; Quwaider, Dalia; Martín-Sánchez, Montserrat; Primo, Daniel; Paíno, Teresa CSIC ORCID; Bergsagel, P. Leif; Mehrling, Thomas; González, Marcos CSIC ORCID ; San Miguel, Jesús F. CSIC ORCID; Mateos, Maria Victoria; Gutiérrez, Norma Carmen; Garayoa, Mercedes CSIC ORCID ; Ocio, Enrique M. CSIC ORCID artículo
openAccesspreclimyel.pdf.jpg2020Preclinical evaluation of the simultaneous inhibition of MCL-1 and BCL-2 with the combination of S63845 and venetoclax in multiple myelomaAlgarín, Esperanza M.; Díaz-Tejedor, Andrea; Mogollón, Pedro; Hernández-García, Susana; Corchete, Luis A.; San-Segundo, Laura; Martín-Sánchez, Montserrat; González-Méndez, Lorena; Schoumacher, Marie; Banquet, Sebastien; Kraus-Berthie, Laurence; Kloos, Ioana; Derreal, Alix; Halilovic, Ensar; Maacke, Heiko; Gutiérrez, Norma Carmen; Mateos, Maria Victoria; Paíno, Teresa CSIC ORCID; Garayoa, Mercedes CSIC ORCID ; Ocio, Enrique M. CSIC ORCID carta al director
openAccessProtein_Paíno_Pv_Art2020.pdf.jpg24-Sep-2020Protein Translation Inhibition is Involved in the Activity of the Pan-PIM Kinase Inhibitor PIM447 in Combination with Pomalidomide-Dexamethasone in Multiple MyelomaPaíno, Teresa CSIC ORCID; González-Méndez, Lorena; San-Segundo, Laura; Corchete, Luis A.; Hernández-García, Susana; Díaz-Tejedor, Andrea; Algarín, Esperanza M.; Mogollón, Pedro; Martín-Sánchez, Montserrat; Gutiérrez, Norma Carmen; Mateos, Maria Victoria; Garayoa, Mercedes CSIC ORCID ; Ocio, Enrique M. CSIC ORCID artículo
closedAccessaccesoRestringido.pdf.jpg2013RAF265, a dual BRAF and VEGFR2 inhibitor, prevents osteoclast formation and resorption. Therapeutic implicationsGarcía-Gómez, Antonio; Ocio, Enrique M. CSIC ORCID ; Pandiella, Atanasio CSIC ORCID CVN ; San Miguel, Jesús F. CSIC ORCID; Garayoa, Mercedes CSIC ORCID artículo
openAccessGarcia Bernal et al.pdf.jpgFeb-2013Sphingosine-1-phosphate activates chemokine-promoted myeloma cell adhesion and migration involving α4β1 integrin functionGarcía-Bernal, David CSIC ORCID CVN; Redondo-Muñoz, Javier ; Dios-Esponera, Ana CSIC; Chèvre, Raphael; Bailón, Elvira CSIC ORCID; Garayoa, Mercedes CSIC ORCID ; Arellano-Sánchez, Nohemí CSIC ; Gutiérrez, Norma C.; Hidalgo, Andrés; García-Pardo, Angeles CSIC ORCID; Teixidó, Joaquín CSIC ORCID artículo
openAccessZaBDeFinalversion.pdf.jpg2017Synergistic DNA-damaging effect in multiple myeloma with the combination of zalypsis, bor tezomib and dexamethasoneLópez-Iglesias, Ana-Alicia; González-Méndez, Lorena; San-Segundo, Laura; Herrero, Ana B.; Hernández-García, Susana; Martín-Sánchez, Montserrat; Gutiérrez, Norma Carmen; Paíno, Teresa CSIC ORCID; Avilés Marín, Pablo; Mateos, Maria Victoria; San Miguel, Jesús F. CSIC ORCID; Garayoa, Mercedes CSIC ORCID ; Ocio, Enrique M. CSIC ORCID artículo
openAccessThe effect of the proteasome.pdf.jpg2008The effect of the proteasome inhibitor bortezomib on acute myeloid leukemia cells and drug resistance associated with the CD34+ immature phenotypeColado, Enrique; Álvarez-Fernández, Stela CSIC; Maiso, Patricia; Martín, Jesús; Vidriales, Maria Belén; Garayoa, Mercedes CSIC ORCID ; Ocio, Enrique M. CSIC ORCID ; Montero, Juan Carlos CSIC ORCID; Pandiella, Atanasio CSIC ORCID CVN ; San Miguel, Jesús F. CSIC ORCIDartículo
openAccessepoxyketone-based.pdf.jpg2013The epoxyketone-based proteasome inhibitors carfilzomib and orally bioavailable oprozomib have anti-resorptive and bone-anabolic activity in addition to anti-myeloma effectsGarcía-Gómez, Antonio; Ocio, Enrique M. CSIC ORCID ; Blanco, Juan F.; Pandiella, Atanasio CSIC ORCID CVN ; San Miguel, Jesús F. CSIC ORCID; Garayoa, Mercedes CSIC ORCID ; Weilbaecher, K. N.artículo
closedAccessaccesoRestringido.pdf.jpg2008The insulin-like growth factor-I receptor inhibitor NVP-AEW541 provokes cell cycle arrest and apoptosis in multiple myeloma cellsMaiso, Patricia; Ocio, Enrique M. CSIC ORCID ; Garayoa, Mercedes CSIC ORCID ; Montero, Juan Carlos CSIC ORCID; Pandiella, Atanasio CSIC ORCID CVN ; San Miguel, Jesús F. CSIC ORCIDartículo
openAccesspanpimcare.pdf.jpg2017The novel pan-PIM kinase inhibitor, PIM447, displays dual antimyeloma and bone-protective effects, and potently synergizes with current standards of carePaíno, Teresa CSIC ORCID; García-Gómez, Antonio; González-Méndez, Lorena; San-Segundo, Laura; Hernández-García, Susana; López-Iglesias, Ana-Alicia; Algarín, Esperanza M.; Martín-Sánchez, Montserrat; Corbacho-González, David; Ortiz-de-Solorzano, Carlos; Corchete, Luis A.; Gutiérrez, Norma Carmen; Mateos, Maria Victoria; Garayoa, Mercedes CSIC ORCID ; Ocio, Enrique M. CSIC ORCID artículo